JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2007; 49:1490-1495, doi:10.1016/j.jacc.2007.02.035 (Published online 20 March 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.02.035v1
49/13/1490    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sick, P. B.
Right arrow Articles by Holmes, D. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sick, P. B.
Right arrow Articles by Holmes, D. R.
Related Collections
Right arrowRelated Article

EXPEDITED REVIEW

Initial Worldwide Experience With the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation

Peter B. Sick, MD*,*, Gerhard Schuler, MD{dagger}, Karl Eugen Hauptmann, MD{ddagger}, Eberhard Grube, MD, FACC§, Steve Yakubov, MD, FACC||, Zoltan G. Turi, MD, FACC, Gregory Mishkel, MD, FACC#, Steve Almany, MD, FACC** and David R. Holmes, MD, FACC{dagger}{dagger}

* Krankenhaus der Barmherzigen Brüder, Regensburg, Germany
{dagger} University of Leipzig, Heart Center GmbH, Leipzig, Germany
{ddagger} Krankenhaus der Barmherzigen Brüder, Trier, Germany
§ Heart Center Siegburg, Siegburg, Germany
|| Midwest Cardiology Research Foundation, Riverside Methodist Hospital, Columbus, Ohio
Cooper Hospital, Camden, New Jersey
# Prairie Education and Research, Springfield, Illinois
** William Beaumont Hospital, Cardiology Center, Royal Oak, Michigan
{dagger}{dagger} Mayo Clinic, St. Mary’s Hospital, Rochester, Minnesota.

Manuscript received February 8, 2007; revised manuscript received February 26, 2007, accepted February 28, 2007.

* Reprint requests and correspondence: Dr. Peter B. Sick, Krankenhaus der Barmherzigen Brüder Regensburg, Medizinische Klinik III/Kardiologie, Prüfeningerstrasse 86, 93049 Regensburg, Germany. (Email: peter.sick{at}barmherzige-regensburg.de).

Objectives: This study assessed the feasibility of implanting a device in the left atrial appendage (LAA) in patients with atrial fibrillation (AF) to prevent thromboembolic stroke.

Background: Meta-analyses confirmed that in cases of left atrial thrombus in nonrheumatic AF patients approximately 90% of them are in the LAA.

Methods: The WATCHMAN Left Atrial Appendage System (Atritech Inc., Plymouth, Minnesota) is a nitinol device implanted percutaneously to seal the LAA. Patients were followed by clinical and transesophageal echocardiography at 45 days and 6 months with annual clinical follow-up thereafter.

Results: Sixty-six patients underwent device implantation. Mean follow-up was 740 ± 341 days. At 45 days, 93% (54 of 58) devices showed successful sealing of LAA according to protocol. Two patients experienced device embolization, both successfully retrieved percutaneously. No embolizations occurred in 53 patients enrolled after modification of fixation barbs. There were 2 cardiac tamponades, 1 air embolism, and 1 delivery wire fracture (first generation) with surgical explantation but no long-term sequelae for the patient. Four patients developed a flat thrombus layer on the device at 6 months that resolved with additional anticoagulation. Two patients experienced transient ischemic attack, 1 without visible thrombus. There were 2 deaths, neither device related. Autopsy documented a stable, fully endothelialized device 9 months after implantation. No strokes occurred during follow-up despite >90% of patients with discontinuation of anticoagulation.

Conclusions: Preliminary data suggest LAA occlusion with the WATCHMAN System to be safe and feasible. A randomized study is ongoing comparing oral anticoagulation with percutaneous closure.

Abbreviations and Acronyms
  AF = atrial fibrillation
  LAA = left atrial appendage
  TEE = transesophageal echocardiography
  TIA = transitory ischemic attack


Related Article

Watching the Watchman
Peter C. Block
J. Am. Coll. Cardiol. 2007 49: 1496-1497. [Full Text] [PDF]



This article has been cited by other articles:


Home page
HeartHome page
Y. L Bayard, S. H Ostermayer, and H. Sievert
Alternatives to warfarin in atrial fibrillation: drugs and devices
Heart, September 1, 2008; 94(9): 1113 - 1116.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The year in interventional cardiology.
J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2355 - 2369.
[Full Text] [PDF]


Home page
EuropaceHome page
J. Koebe and P. Kirchhof
Novel non-pharmacological approaches for antiarrhythmic therapy of atrial fibrillation
Europace, April 1, 2008; 10(4): 433 - 437.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Stollberger and J. Finsterer
WATCHMAN for Stroke Prevention: An Out-of-Date Procedure
J. Am. Coll. Cardiol., August 28, 2007; 50(9): 914 - 914.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Sick
Reply
J. Am. Coll. Cardiol., August 28, 2007; 50(9): 914 - 915.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. C. Block
Watching the Watchman
J. Am. Coll. Cardiol., April 3, 2007; 49(13): 1496 - 1497.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.